Spring Bioscience Corporation（Spring）开发和生产设计用于IHC的兔单克隆抗体。由主要关注IHC的科学家创建，Spring开发了一种高灵敏度“SP”克隆的专有抗体菜单，可以产生特异性和一致性，用于研究。Spring于2007年被Ventana Medical Systems，Inc.(Ventana)收购，因为其强大的开发能力，此后不久Ventana被罗氏收购。今天，Spring作为所有罗氏组织诊断的抗体中心。

Spring Bioscience Corporation (Spring) develops and manufactures rabbit monoclonal antibodies designed for use in IHC. Founded by scientists with a primary focus on IHC, Spring has developed a proprietary antibody menu of highly-sensitive “SP” clones that yield specificity and consistency for use in research. Spring was acquired by Ventana Medical Systems, Inc. (Ventana) in 2007 for its strong development capabilities, and shortly thereafter Ventana was acquired by Roche. Today Spring serves as the antibody center of excellence for all of Roche Tissue Diagnostics.

产品列表：